Research Study Proves Calmer Canine Veterinary Therapy Device Resolves Separation Anxiety in Dogs
07 Février 2022 - 7:51PM
InvestorsHub NewsWire
Northvale, NJ -- February 7, 2022 -- InvestorsHub NewsWire --
ADM Tronics Unlimited, Inc. (OTCQB:
ADMT) announced that a study recently conducted by North
Carolina State University (“NCSU”) on the Calmer Canine
non-invasive electrotherapy device, demonstrated conclusively that
it is an effective treatment for canine separation anxiety (“CSA”).
The study conducted by NCSU on the Calmer Canine in the
treatment of dogs with CSA was double-blind, randomized and
placebo-controlled - the “gold standard” for efficacy evaluations
of therapeutic technologies. By the fourth week in the study
nearly two-thirds of the dogs exhibited 100% greater improvement in
the time spent resting instead of anxious when home alone.
Data collected via video analysis of the dogs when alone was
analyzed by researchers to more accurately gauge the severity of
CSA.
The Calmer Canine was developed for Assisi Animal Health
(“Assisi”) by ADMT and is being manufactured at ADMT’s Northvale,
NJ medical device manufacturing facility. ADMT also
developed and manufactures Assisi’s Veterinary Loop
Anti-Inflammatory Therapy devices.
The Calmer Canine is a highly innovative, gentle, effective,
safe and drug-free treatment system for CSA which is anxiety or
fear-related behavior that occurs when an owner leaves their dog
alone. The Calmer Canine device delivers targeted pulsed
electromagnetic field (tPEMF) signals non-invasively to the area of
the brain responsible for causing the symptoms of anxiety. It
effectively returns the anxious brain to a more balanced emotional
state with long-lasting effects.
The Calmer Canine, applied in two 15-minute treatments per day
for 4 to 6 weeks, effectively reduces CSA symptoms, such as
incessant barking, destructive behavior and inappropriate
urination. In many cases, results can be seen in a short
amount of time. In the NCSU study, half of the owners
reported improvement in their dog’s anxiety after just one week of
treatments.
Approximately 17% or 13 million dogs in the US alone are
estimated to suffer from CSA. An effective, non-invasive,
non-pharmaceutical therapy can be a major benefit in reducing
surrenders to shelters, reducing euthanasia and significantly
improving the relationship between owners and their dogs.
In addition to resolving CSA, Assisi reports that there has been
anecdotal evidence that the Calmer Canine reduces many other types
of anxiety, from stranger anxiety to noise phobia.
View a video on Calmer Canine at this link: https://www.youtube.com/watch?v=X4BSCurq9nE&t=9s
See the NCSU study at: https://www.frontiersin.org/articles/10.3389/fvets.2021.775092/full
For more information about Calmer Canine and Loop technologies
visit assisianimalhealth.com. Calmer Canine® is an Assisi
Animal Health trademark – all rights reserved.
ADMT welcomes inquiries for its electronics and medical device
development and manufacturing services at www.admtronics.com.
To receive email updates from ADMT, fill in the form at the
bottom of the page at this link: https://admtronics.com/investor-relations/
About ADMT
ADMT is a diversified, technology-based developer and
manufacturer of innovative technologies and products. Its
core competency is its ability to conceptualize a technology, bring
it through development, into manufacturing and commercialization,
all in-house. ADMT has three areas of activity: Proprietary
Medical Devices; Medical Device Design, Engineering, Regulatory and
Manufacturing Services; and Eco-Friendly, Water-Based
Formulations. The Company’s headquarters, laboratories,
FDA-Registered medical device and manufacturing operations are in
Northvale, NJ. ADMT’s multi-disciplinary team of engineers,
researchers and technologists utilize advanced technology
infrastructure, such as rapid 3-D prototyping, precision
instrumentation and specialized software and peripherals, for
research, development and commercialization of diversified
technologies. Additional information is available at the Company’s
website - admtronics.com.
Except for historical information contained herein,
the matters set forth in this news release are “forward looking”
statements (as defined in the Private Securities Litigation Reform
Act of 1995), including statements regarding future revenue growth
and performance. Although ADMT believes the expectations
reflected in such forward looking statements are based upon
reasonable assumptions, there can be no assurance that its
expectations will be realized. Forward looking statements involve
risks and uncertainties that could cause actual results to differ
materially from expectations. Factors that could contribute
to such differences include those described from time to time in
ADMT’s SEC filings, news releases and other communications. The
Company assumes no obligation to update information contained in
this news release.
Andre DiMino
andre@admtronics.com
Adm Tronics Unlimited (QB) (USOTC:ADMT)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Adm Tronics Unlimited (QB) (USOTC:ADMT)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024